Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Anticoagulation for the prevention of venous thromboembolization is underutilized worldwide. Risk of short-term interruption of warfarin therapy appears small. Treatment with idraparinux increases hemorrhage risk, as compared with vitamin K antagonists.

Prevention of Thromboembolism: Is There Hope?